186 related articles for article (PubMed ID: 29908999)
1. The roles of PAI-1 gene polymorphisms in atherosclerotic diseases: A systematic review and meta-analysis involving 149,908 subjects.
Liu Y; Cheng J; Guo X; Mo J; Gao B; Zhou H; Wu Y; Li Z
Gene; 2018 Oct; 673():167-173. PubMed ID: 29908999
[TBL] [Abstract][Full Text] [Related]
2. Genetic association between plasminogen activator inhibitor-1 rs1799889 polymorphism and venous thromboembolism: Evidence from a comprehensive meta-analysis.
Huang G; Wang P; Li T; Deng X
Clin Cardiol; 2019 Dec; 42(12):1232-1238. PubMed ID: 31701558
[TBL] [Abstract][Full Text] [Related]
3. PAI-1 Polymorphisms Have Significant Associations With Cancer Risk, Especially Feminine Cancer.
Wang J; Peng Y; Guo H; Li C
Technol Cancer Res Treat; 2021; 20():15330338211037813. PubMed ID: 34521295
[TBL] [Abstract][Full Text] [Related]
4. Correlation between
Geng B; Li S; Zhou J; Feng G
Phlebology; 2020 Aug; 35(7):472-479. PubMed ID: 31948344
[TBL] [Abstract][Full Text] [Related]
5. The Roles of TLR Gene Polymorphisms in Atherosclerosis: A Systematic Review and Meta-Analysis of 35,317 Subjects.
Xie X; Shi X; Liu M
Scand J Immunol; 2017 Jul; 86(1):50-58. PubMed ID: 28474755
[TBL] [Abstract][Full Text] [Related]
6. Influence of interleukin-6 gene -174G>C polymorphism on development of atherosclerosis: a meta-analysis of 50 studies involving 33,514 subjects.
Yin YW; Li JC; Zhang M; Wang JZ; Li BH; Liu Y; Liao SQ; Zhang MJ; Gao CY; Zhang LL
Gene; 2013 Oct; 529(1):94-103. PubMed ID: 23954871
[TBL] [Abstract][Full Text] [Related]
7. Association of PAI-1 rs1799889 Polymorphism with Susceptibility to Ischemic Stroke: a Huge Meta-Analysis based on 44 Studies.
Jafari M; Jarahzadeh MH; Dastgheib SA; Seifi-Shalamzari N; Raee-Ezzabadi A; Sadeghizadeh-Yazdi J; Akbarian E; Neamatzadeh H
Acta Medica (Hradec Kralove); 2020; 63(1):31-42. PubMed ID: 32422114
[TBL] [Abstract][Full Text] [Related]
8. Association between the plasminogen activator inhibitor-1 4G/5G polymorphism and risk of venous thromboembolism: a meta-analysis.
Wang J; Wang C; Chen N; Shu C; Guo X; He Y; Zhou Y
Thromb Res; 2014 Dec; 134(6):1241-8. PubMed ID: 25450536
[TBL] [Abstract][Full Text] [Related]
9. Association between plasminogen activator inhibitor-1 gene polymorphisms and susceptibility to Parkinson's disease in Chinese patients.
Xu Q; Lai Q; Wang J; Zhuang L; Cheng L; Mo Y; Liu L; Zhao Z; Zhang Y; Weng S; Qiao S
Acta Neurol Belg; 2022 Dec; 122(6):1557-1566. PubMed ID: 34845645
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic gene polymorphism and ischemic stroke.
Jood K; Ladenvall P; Tjärnlund-Wolf A; Ladenvall C; Andersson M; Nilsson S; Blomstrand C; Jern C
Stroke; 2005 Oct; 36(10):2077-81. PubMed ID: 16179568
[TBL] [Abstract][Full Text] [Related]
11. Significant associations of PAI-1 genetic polymorphisms with osteonecrosis of the femoral head.
Kim H; Cho C; Cho Y; Cho S; Yoon K; Kim K
BMC Musculoskelet Disord; 2011 Jul; 12():160. PubMed ID: 21752301
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor-1 gene: selection of tagging single nucleotide polymorphisms and association with coronary heart disease.
Su S; Chen S; Zhao J; Huang J; Wang X; Chen R; Gu D
Arterioscler Thromb Vasc Biol; 2006 Apr; 26(4):948-54. PubMed ID: 16424345
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen Activator Inhibitor-1 Polymorphisms and Risk of Coronary Artery Disease: Evidence From Meta-Analysis and Trial Sequential Analysis.
Tabaei S; Omraninava M; Mehranfar S; Motallebnezhad M; Tabaee SS
Biochem Genet; 2022 Oct; 60(5):1409-1445. PubMed ID: 35039979
[TBL] [Abstract][Full Text] [Related]
14. A meta-analysis on relationship between paraoxonase 1 polymorphisms and atherosclerotic cardiovascular diseases.
Zeng Q; Zeng J
Life Sci; 2019 Sep; 232():116646. PubMed ID: 31302193
[TBL] [Abstract][Full Text] [Related]
15. Plasminogen activator inhibitor type 1 gene polymorphisms and haplotypes are associated with plasma plasminogen activator inhibitor type 1 levels but not with myocardial infarction or stroke.
Ding J; Nicklas BJ; Fallin MD; de Rekeneire N; Kritchevsky SB; Pahor M; Rodondi N; Li R; Zmuda JM; Harris TB
Am Heart J; 2006 Dec; 152(6):1109-15. PubMed ID: 17161063
[TBL] [Abstract][Full Text] [Related]
16. Pai-1 gene variants and COC use are associated with stroke risk: a case-control study in the Han Chinese women.
Huang X; Li Y; Huang Z; Wang C; Xu Z
J Mol Neurosci; 2014 Dec; 54(4):803-10. PubMed ID: 25231632
[TBL] [Abstract][Full Text] [Related]
17. Plasminogen activator inhibitor-1 4G/5G and the MTHFR 677C/T polymorphisms and susceptibility to polycystic ovary syndrome: a meta-analysis.
Lee YH; Song GG
Eur J Obstet Gynecol Reprod Biol; 2014 Apr; 175():8-14. PubMed ID: 24439532
[TBL] [Abstract][Full Text] [Related]
18. Association between the SERPINE1 (PAI-1) 4G/5G insertion/deletion promoter polymorphism (rs1799889) and pre-eclampsia: a systematic review and meta-analysis.
Zhao L; Bracken MB; Dewan AT; Chen S
Mol Hum Reprod; 2013 Mar; 19(3):136-43. PubMed ID: 23180602
[TBL] [Abstract][Full Text] [Related]
19. Association between plasminogen activator inhibitor-1 gene polymorphisms and recurrent pregnancy loss: a systematic review and meta-analysis.
Chen H; Nie S; Lu M
Am J Reprod Immunol; 2015 Apr; 73(4):292-300. PubMed ID: 25250948
[TBL] [Abstract][Full Text] [Related]
20. Lack of Associations Between
Sarecka-Hujar B; Kopyta I; Skrzypek M
Clin Appl Thromb Hemost; 2019; 25():1076029619869500. PubMed ID: 31530188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
